Concepedia

A. Lortholary

AL

Statistics

Publications

2

Citations

370

H-Index

2

Active since

2019

Affiliations

Spital Uster(Current)

A. Lortholary is an author at Spital Uster specializing in ovarian cancer clinical trials, ovarian cancer pharmacotherapy, and gynecologic cancer pharmacotherapy.

Publications per year

2019–2023

2

Publications

2

Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

I. Ray-Coquard, Alexandra Léary, Sandro Pignata et al. · Annals of Oncology · 2023 · 339 citations · Full text

, , +15

Phase III PAOLA-1/ENGOT-ov25 trial: Olaparib plus bevacizumab (bev) as maintenance therapy in patients (pts) with newly diagnosed, advanced ovarian cancer (OC) treated with platinum-based chemotherapy (PCh) plus bev

Isabelle Laure Ray-Coquard, P. Pautier, S. Pignata et al. · Annals of Oncology · 2019 · 31 citations · Full text

, , +14

1–2 of 2